![Übergabe des Förderbescheids in Höhe von 12,1 Mio Euro: (v.l.n.r.) Prof. Gabriele Gillessen-Kaesbach, Präsidentin der Universität zu Lübeck, Prof. Thorsten Buzug, Geschäftsführender Direktor der Fraunhofer IMTE, Daniel Günther, Ministerpräsident Schleswig-Holstein, Prof. Philipp Rostalski, Direktor Fraunhofer IMTE, Prof. Reimund Neugebauer, Präsident der Fraunhofer-Gesellschaft. © Fraunhofer IMTE | Reiner Jensen / Handover of the funding decision in the amount of 12.1 million euros: (from left to right) Prof. Gabriele Gillessen-Kaesbach, President of the University of Lübeck, Prof. Thorsten Buzug, Executive Director of Fraunhofer IMTE, Daniel Günther, Minister President of Schleswig-Holstein, Prof. Philipp Rostalski, Director of Fraunhofer IMTE, Prof. Reimund Neugebauer, President of the Fraunhofer-Gesellschaft. © Fraunhofer IMTE | Reiner Jensen Übergabe des Förderbescheids in Höhe von 12,1 Mio Euro: (v.l.n.r.) Prof. Gabriele Gillessen-Kaesbach, Präsidentin der Universität zu Lübeck, Prof. Thorsten Buzug, Geschäftsführender Direktor der Fraunhofer IMTE, Daniel Günther, Ministerpräsident Schleswig-Holstein, Prof. Philipp Rostalski, Direktor Fraunhofer IMTE, Prof. Reimund Neugebauer, Präsident der Fraunhofer-Gesellschaft. © Fraunhofer IMTE | Reiner Jensen / Handover of the funding decision in the amount of 12.1 million euros: (from left to right) Prof. Gabriele Gillessen-Kaesbach, President of the University of Lübeck, Prof. Thorsten Buzug, Executive Director of Fraunhofer IMTE, Daniel Günther, Minister President of Schleswig-Holstein, Prof. Philipp Rostalski, Director of Fraunhofer IMTE, Prof. Reimund Neugebauer, President of the Fraunhofer-Gesellschaft. © Fraunhofer IMTE | Reiner Jensen](/uploads/images/_scale/pi10zvstartschussfuerdiefraunhoferimte_169_626x352.jpg)
Funding decision delivered
The Fraunhofer Research Institution for Individualized and Cell-Based Medical Engineering IMTE gets the green light
Individualized medical engineering is the answer to a growing demand for precision diagnostic techniques that identify patient-specific and disease-specific influencing factors and use these to develop highly effective prevention, diagnosis and treatment procedures with few side effects. This is at…